Unknown PHASE4 INTERVENTIONAL 4-arm NCT01660386

Study of Comparing the Different Effect of DPP-4 Inhibitors and Sulfonylurea by Using Biphase-Hyperglycemic Clamp

An Open-label, Randomized, Four-way Cross-over, Single Dose Study to Compare the Different Effect of DPP-4 Inhibitors and Sulfonylurea on the Beta Cell Function by Using Biphase-Hyperglycemic Clamp

Sponsor: Shanghai Jiao Tong University School of Medicine

Conditions Type 2 Diabetes

Interventions Blank control Glimepiride Saxagliptin Sitagliptin

Updated 5 times since 2017 Last updated: Dec 13, 2012 Started: Jul 31, 2012 Primary completion: Dec 31, 2012 Completion: Mar 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Type 2 Diabetes and is currently ongoing. Shanghai Jiao Tong University School of Medicine leads this study, which shows 5 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Jul 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shanghai Jiao Tong University School of Medicine

Data source: Shanghai Jiao Tong University School of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China